• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    This disclosure describes a new antibiotic designated BL580 DELTA produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces hygroscopicus and mutants thereof. This new antibiotic is an active anticoccidial agent.
    公开号:SU715034A3
    申请号:SU772497857
    申请日:1977-06-29
    公开日:1980-02-05
    发明作者:Генри Эдвард Джеймс Мартин Джон；Роуд Херц Мартин
    申请人:Американ Цианамид Компани (Фирма)；
    IPC主号:
    专利说明:

    one
    The invention relates to the field of microbiology and relates to the synthesis of a new antibiotic, the method of production of which is not described in the patent and scientific literature.
    The proposed method of obtaining antibiotic form.
    On agar with caster flakes, aerial mycelium gives spore-bearing branches ending in tightly folded spirals of several turns. Spores, most of which are not round, articulate. The size of the spores of 0.6-0.8 microns. The surface of the dispute is smooth. Spore shells are thinly morgpiky,
    Agar Čapek, Growth is weak. Traces of whitish aerial mycelium. There is no sporulation. Soluble pigment is absent, Substrate mycelium from colorless to whitish.
    Medium with yeast extract. Growth is good. Aerial mycelium is whitish, from light to dark brown in areas of sporulation. Sporiation is abundant. The soluble pigment is yellowish, Substitutny my celi yellow. Blackish hygroscopic surfaces in the central eons of colonies in
    Wednesday with asparagine-dextrose. Growth is moderate. Aerial mycelium whitish, from ashy to light brown in areas of sporulation. Sporulation moderate. Soluble pigment is missing. Substrate mycelium yellow. Blackish hygroscopic surfaces in the central zones of the colonies,
    Wednesday with starch. Growth is moderate. Aerial mycelium from whitish-yellowish, from light to dark brown in sporulation areas. Sporulation is abundant. Soluble pigment is absent, Substractive mycelium is pastel yellow, Blackish hygroscopic surfaces of the central zones of the colonies.
    Agar Bennet. Growth moderate. Aerial whitish mycelium. Dark brown in sporulation zones. Soluble pigment yellowish, Substrate mycelium: yellow. Blackish hygroscopic surfaces in the central zones of the colonies,
    Agar potato-dextrose, Growth Horgoa. Aerial mycelium from whitish to. yellowish, from ash to brown in brown sporulation. Sporulation moderate. Soluble pigment is yellowish, light, Substructure mycelium is yellowish-green. Blackish hygroscopic surfaces in the central zones of the colonies.
    Physiological and biochemical signs
    Nitrates restores nitrites. Gelatinu dilutes completely, does not form melanoid pigments. On the seventh day the milk completely pentonized.
    Tolerance NaC & in the culture medium 7-10%,
    Adonitol, d-galactose, d-fructose, d-raffinose, salicin, d-xylose and dextrose are well absorbed.
    Poorly absorbs d-melezitosis, d-melibiosis. Does not assimilate 6-arabinose,
    E-inositol, lactose, d-mannitap, K-rhamnose, sucrose and b-trehalose. The cultivation of the St.ti gToscopicus NRRL 8180 strain is carried out in very diverse environments containing digestible carbon sources, for example, starch, sugar, molasses, glycerin, nitrogen, for example protein, protein hydrolyzate, polypeptides, and insulin acids corn infusion, mineral salts, for example, potassium salts, sodium, calcium, sulfates, phosphates, chlorides. Trace elements, such as boron, molybdenum, copper come along with other components of the environment. Aeration is carried out by surface or deep method with mechanical stirring, sometimes with the addition of antifoaming agent, for example, 1% octadecanol in margarine.
    The seed of St.ti: groscoptcu5 is prepared by infecting 100-ml portions of sterile medium in 500-ml flasks by scraping or by removing spores from oblique agar culture. The following medium is usually used, wt.%: Soybean flour1.0 Glucose2, 0
    Corn infusion 0,5 Calcium carbonate 0,3 Water Else
    Flasks are incubated at 25–29 ° Cf, preferably at, and shaken vigorously for 48–96 h.
    Two 100-ml portions of inoculum are seeded with 12 liters of sterile medium in 20-liter bottles and mixed with aeration and 25-29 ° C, preferably 2.8 seconds, for 36-64 hours.
    The resulting material is inoculated with 300 l of the same sterile medium in a fermenter, stirred for 36-64 h at 25-29 ° C, preferably with, and aeration.
    This seed is used for seeding a 4000-liter fermenter containing a 3000 liter sterile medium having the following composition, wt%; Corn infusion 0.5 Soev flour1.0
    Corn starch 4,0 Calcium carbonate 0,1 WaterOstal
    This medium is fermented for 100-200 hours with 27-32 s, stirring with a stirrer and aeration (0.4-0.8 l of air per 1 l per 1 l of cpenji). Add a defoaming agent, for example, Hdag FT) 82, in an amount of 1.3. hours at 1000 hours of environment
    The resulting mass containing the antibiotic BL 508 is mixed with half the volume of ethyl acetate and stirred for 2-3 hours. Add 8% of the diatomaceous earth, filter on a frame filter (cps, filter cake washed in the filter press with ethyl acetate, the filtrate and washings are concentrated to a syrup, stirred with a double volume of heptane and left overnight when the upper layer is decanted to concentrate to a gummy residue.
    The gummy residue is treated with 10 liters of methanol and cooled for several hours with dry ice, filtered through sintered glass coated with diatomaceous earth, and washed with cold methanol. The methanol solution is concentrated under vacuum to dryness, the residue is dissolved in methylene chloride (40 g / l) and passed through a column filled with activated carbon (1 liter of carbon per 50 g of load), the eluate is concentrated to dryness, the residue is mixed with methanol, cooled with dry ice for 15 minutes to -10 ° C, the frozen oil is filtered, the filtrate is concentrated in vacuum dry and get butter.
    This oil is dissolved in a minimum amount of methylene chloride, mixed with silica gel, evaporated to dryness and loaded onto dry, chemical silica gel. Elute first with 10% and then a 201% solution of ethyl acetate in benzene, allow the column to drain, divide it into 10 equal parts {including loading), take nozzle samples, 05, 0.15, 0.25, and t, e , along the length of the entire column and elute the approach with 1d volume of a mixture of ethyl acetate - methylene chloride-methanol (3: 2: 1). In places where the antibiotic bands overlap, the selection is made through each. The presence of the antibiotic is determined according to those for charring in the presence of sulfuric acid.
    Samples of 0.11-0.35 cut out from the column and vzmuchivayut in a mixture of ethyl schistat-methylene chloride-methanol (2: 2: 1 by volume), filtered, washed with a mixture of solvents and concentrated in vacuo to dryness. The residue is dissolved in t-butanol, filtered, lyophilized and a fluffy solid is obtained.
    The lower phase of the n-heptane ethyl acetate-methanol-water system (3000 g 1500:: 75: 37 by volume) is mixed with diatomaceous earth (800 g of the earth with 600 ml of phase), a mixture of 40 g of diatrmitic is loaded into a column (diameter 7.5 cm) segres (per 800 g of soil, 600 ml of the phase) are loaded into the column and eluted with the upper phase of this system, the 25 ml fractions are selected. The presence of the antibiotic in the fractions is determined by the method of those in the chloroform-ethyl acetate system and by charring, Fractions 90-150 they are concentrated, and the antibiotic BU 508 &
    Example 1, Sterile medium containing, g:
    1.0
    Soyeva flour
    2.0.
    Glucose
    0.5
    Corn infusion
    0.3
    Calcium Carbonate
    Up to 100 MP
    Water
    they infect with spores of scouring agar or with scouring. St.h jgToscopicue. Two. 500 ml flasks containing 100 ml of the indicated medium are used. The flasks are shaken vigorously for 72 hours at 28 ° C.
    0
    The resulting material was transferred from a 500 ml flask to a bottle containing 12 liters of the same medium and fermented for 48 hours during aeration.
    Then they are subcultured into a fermenter, containing 5 liters of the same sterile medium, and mixed (173 rpm) with aeration (1 liter of air and 1 liter of E 1 NMH medium) for 48 hours at 28 ° C, maintaining pH 6.9-7 , 0,
    Example 2. Wednesday, containing, g :. .
    Corn infusion 0.5
    Soyeva flour1.0
    Corn starch4.0
    Calcium carbonate 0.1
    five
    WaterIt 100 ml
    sterilized at 120 ° C and pH 6.4-6.5 for 60 minutes. 3000 l of the medium are seeded with 300 l of the material obtained in example 1, fermented at 28Q, aeration (0.6 l of air per 1 l of medium in 1 NIKH) and stirring (150 rpm) in the presence of 4 l of anti-foaming agent for 138.5 h in a 4000-l fermenter.
    five
    Example 3. 2550 L (pH 7.4) of the mass after fermentation, obtained as in Example 2, and 1275 L of ethyl acetate were re-stirred for 2.5 hours. 8% of diatomaceous earth was added, filtered in several portions on a pair of frame filter presses , The filtrate (3250 l) is allowed to stand and the ethylatetate layer (1000 l) is separated. After filtering each portion of the cake, the cake is squeezed in the filter press with ethyl acetate, washed 5 kg of rgd. Kgg, left to stand and the ethyl acetate layer (535 l ), EGIL-acetate layers are first concentrated to 225 liters, then to 20 liters. These 20 liters are concentrated in a glass distillation and until syrup is obtained.
    The syrup is kept for 48 hours at 4 ° C, mixed with a double volume of heptane and left overnight at 4 ° C,
    5 The upper layer is separated by decantation and concentrated to a gummy residue.
    10 liters of methanol are added to the PROMINANT residue, cooled with dry ice.
    0 a few hours, filtered through a sintered glass covered with diatomaceous earth, and cold methanol. The combined filtrates and washes are concentrated to dryness in
    5 vacuum and get 1353.6 g of residue.
    1353j6 g of the residue is dissolved in methylene chloride (40 g / l) and passed through a column filled with 27.07 granular coal (20 x 40 mesh) at a speed of 375-400 ml / min. The eluate is concentrated to dryness, the residue, (1053 g) is thoroughly mixed with 89 l of methanol, cooled to-10 ° C with dry ice and incubated for 15 clays at, the frozen oil is filtered, the filtrate is concentrated to dryness and 781.4 g of oil are obtained, 200 g of oil is dissolved in the minimum quality of methylene chloride, 300 g of silica gel are added, mixed thoroughly, evaporated in vacuo to dryness and. load in plastic SPEAKER; filled with 4 kg of silica gel, on top of a cliddles / t a little sea sand to prevent the elution layer from breaking, lute 12 l of ethyl acetate in benzene, allow to drain and elute with 7p6 l of 20% ethyl acetate in benzene, From the fraction, bark The column was stripped and purged with nitrogen. Streptococcus p-sogenes was used to determine the antibiotic activity of the fraction. The column is divided into 10 equal parts (including loading) e. Nozzle samples are taken at, 05, 0.15, 0.25, 0.35 and t, d, in d / guine of the whole column. In places where the antibiotic bands overlap, selection is made every 1/8 Rf. Each sample 10 ml of a mixture of ethyl acetate and methylene chloride (2: 2: 1) are eluted, and according to those in the ethyl acetate system chloroform (1: 1), the presence of an antibiotic is determined by charring in the presence of sulfuric acid.
    Samples cTijO, 11-0, 35 are cut out from the column and vortexed in a mixture of ethyl acetate-chloride. methylene-methanol (2:: 2: 1), filtered, washed with the same mixture of solvents and concentrated in vacuo to dryness. The residue is dissolved in t-butanol, lyo-yzed and 26.7 g of product is obtained,
    600 ml of the lower phase of the system n-heptane-methanol-ethyl acetate-water (3000: 1500: 75: 37 by volume) and 800 i- washed with acid of diato 1-tite earth are mixed, and a mixture consisting of 40 g of diatomaceous earth is mixed into a glass core , 30 ml of the lower phase of this system and .13.8 g of the lyophilized product are eluted with the upper phase of the indicated solvent system and fractions are collected according to
    25 ml, which are analyzed by the method of those. Fractions 90-150 are pooled and 2.75 g of antibiotic Bb 508i are obtained in the form of sodium salt.
    Example 4 600 ml of the lower phase of the heptane-methanol-ethyl acetate-water system (3000: 1500: 80: 40 by volume) and 800 g of earth diatomaceous earth are mixed
    A mixture of 28 g of diatomaceous earth, 21 ml of the indicated lower phase, 10.9 g of the antibiotic VOZD as sodium salt is loaded into the column, eluted with the upper phase of the indicated system, and 90 ml fractions are selected. According to the data on the plates silplate
    F 22 in the system of ethyl acetate-chloroform and for charring is judged to be antibiotic. Fractions 29-39 are combined, concentrated, and solid. the residue is dissolved in t-butanol, lyophilized, and 4.79 g of product are obtained,
    800 mg of the lyophilized product are mixed with 300 ml of a mixture of water-ether-petroleum ether (2: 1: 1). While stirring, 1N hydrochloric acid is added to a pH of 2.5. The organic phase is separated and washed three times with equal volumes of water, concentrated in vacuo, the residue is dissolved in tert-butanol, lyophilized, and 657 mg of the antibiotic Bb508l is obtained in the form of the free acid, fotj -f21 ± 1 ° (c 0.9, methanol),
    Found,%: e 61.1; H 8.9; ash O - IR spectrum, micron: 2,95; 5.88; . 8.35; 8.60; 9.00; 9.12; 3.43; 9.62; 10.05 and 10.47,
    Example 5, 1g of the antibiotic Bb508d in the form of free acid is dissolved in 300 ml of ether-petroleum ether (D: 1), added to 200 ml of water, 0.1 N hydrochloric acid is added with stirring to pH 10 0, the organic phase is concentrated in vacuo, the residue is dissolved in 10 ml of ether, 20 ml of petroleum ether (30-70 ° e) and a crystal of the sodium salt of the antibiotic BU 508l are added, kept at 4 °, the crystals are washed with cold petroleum ether, air-dried and get 323 mg of sodium salt antibiotic B1, 508y., t, pcs. 157-161 ° e; + 6 ± 1 ° (s, methanol),
    Found,%: C 60.99; H 8.47; Na 1.95 ,. .
    IR spectrum, micron: 6.27; 7.28; 9.0; 9.13; 9.48 and 10.60,
    Example 6, 1g of antibiotic BU 508D as sodium salt, 834 mg of p-bromophenacyl bromide, 600 mg of lithium carbonate and 20 ml of dry dimethylformamide are incubated for 16 hours at 37 ° e, 4-fold volume of chloroform is added, filtered, the filtrate is concentrated in vacuo and a syrup-like residue is obtained, 90 ml of the lower phase of the heptane-ethyl acetate-methanol-water system (200: 25: 1000: 17) is dispensed with 120 g of diatomaceous earth, a syrup-like residue is loaded into the column, 12 g of diatomaceous earth and 9 ml of the lower phase of this system, eluted the upper phase, selecting the fraction of 10 ml. The activity of the fractions is determined by the method of those. Fractions 22-41. combined and concentrated in vacuo, the residue is dissolved in 50 ml of methanol and filtered. The filtrate is heated on a steam yen, 10 ml of water are added and allowed to cool slowly to 4 ° C. 566 mg of bromophenyl crystals of the antibiotic BU 508d, 1: L3 5: - "- bZ ± 2 ° (c 51, chloroform) are obtained. Found %: C 58.80; H 7.80 Bg 8.64, KM- 2.9 6.30; 8.20; 8.45; 8, BO; 9.00; 9.15 (wide) 9.37 (wide); 9.62; 10.06 and.
    X "Gb
    characterized in that the Siif-epiowces iisef-oscopicus, 8180 is grown under aerobic conditions in a liquid, nutrient medium containing
    Oh, in CHj
    H he
    emitting sources of carbon, nitrogen and mineral Sapi, followed by release of the target product. 4 Molecular weight iadugiaraty p-bromfenaciloBogo afiry B). 508., determined by X-ray diffraction, is equal to 1 i i 4 t О ,, 3 8, the Proposed method allows to obtain an antibiotic in 1 508th, which has high activity against coccal infections of warm-blooded animals and low toxicity. Invention Method A method for preparing an antibiotic of formula
    权利要求:
    Claims (1)
    [1]
    Claim
    A method of obtaining an antibiotic of the formula
    H — C — H I <JO 2 H characterized in that the strain. Sirep-tohrsces hig'roscopicus® 8180 is grown in aerobic, liquid, culture medium, containing
    30 sources of carbon, nitrogen, and mineral salts, followed by the isolation of the target product.
    类似技术:
    公开号 | 公开日 | 专利标题
    US4555402A|1985-11-26|Physiologically active substance K-252, process for producing same and pharmaceutical composition containing same
    FR2461001A1|1981-01-30|CULTURE OF THE MICROORGANISM STREPTOMYCES ZELENSIS
    SU715034A3|1980-02-05|Method of preparing bl508-delta antibiotic
    AU602327B2|1990-10-11|Novel glycopeptide antibiotics
    SU786914A3|1980-12-07|Method of preparing antibiotic complex
    FR2555586A1|1985-05-31|ANTIBIOTIC COMPLEX BBM-2478
    Ono et al.1983|MILBEMYCINS, A NEW FAMILY OF MACROLIDE ANTIBIOTICS FERMENTATION, ISOLATION, PHYSICO-CHEMICAL PROPERTIES AND BIOCONVERSION OF MILBEMYCINS J AND K
    NL192621C|1997-11-04|Method for the preparation of new antibiotics, which belong to the macrolides, microorganisms of the strain Micromonospora, which are capable of producing these new antibiotics; and new antibiotics and pharmaceutical preparations.
    GB2111985A|1983-07-13|Pyrrolomycin e
    EP0300273B1|1994-03-23|AB-006 antibiotics and process for their production
    SU1442063A3|1988-11-30|Method of producing herbicide number 51262
    EP0236894B1|1994-11-09|Efomycine G, its preparation and its use as an animal growth promotor
    AU657011B2|1995-02-23|Antibiotic AB-041 and the process for its production
    EP0235795B1|1991-09-04|Antibiotic f-0769, process for its production, and its use as a growth accelerating and feed efficiency increasing agent and as an antitumour agent
    AU655853B2|1995-01-12|Antibacterial substance BE-24566B
    AU686920B2|1998-02-12|Novel aminooligosaccharide derivative and process for preparing the same
    US4202886A|1980-05-13|Antibiotic SF-1942 substance and process for production of the same
    US4189537A|1980-02-19|Process of producing antibiotic BL580Δ with Streptomyces hygroscopicus
    US3974035A|1976-08-10|Process for preparing a cephamycin type antibiotic substance
    SU741804A3|1980-06-15|Method of preparing antibiotic
    SU618053A3|1978-07-30|Method of obtaining antibacterial substance
    JP2966859B2|1999-10-25|Novel bioactive substance dioctatin and method for producing the same
    KR810001709B1|1981-10-27|Process for production of antibiotic bl 580 delta
    US4197292A|1980-04-08|Novel amylase inhibitors
    CA1093999A|1981-01-20|Antibiotic bl580.delta. from streptomyces hygrosicopieus
    同族专利:
    公开号 | 公开日
    CS207462B1|1981-07-31|
    US4138481A|1979-02-06|
    ZA773288B|1978-04-26|
    BE856314A|1977-12-30|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3595955A|1969-03-26|1971-07-27|Upjohn Co|Geldanamycin and process for producing same|
    US3812249A|1972-11-24|1974-05-21|American Cyanamid Co|Antibiotic bl580|
    US4024251A|1974-08-13|1977-05-17|Merck & Co., Inc.|Antibiotic FR-02A and therapeutic compositions thereof|US4232006A|1977-02-09|1980-11-04|Schering Corporation|Antibiotic W-10 complex, antibiotic 20561 and antibiotic 20562 as antifungal agents|
    US4263427A|1978-11-29|1981-04-21|Hoffmann-La Roche Inc.|Monensin urethane derivatives|
    US4294925A|1979-09-20|1981-10-13|Hoffmann-La Roche Inc.|Monensin urethane derivatives produced by streptomyces|
    JPS5592387A|1978-12-29|1980-07-12|Taisho Pharmaceut Co Ltd|Antibiotic substance tm-531|
    US4278663A|1980-01-30|1981-07-14|Hoffmann-La Roche Inc.|Antibiotic X-14868A, B, C and D|
    JPS6321679B2|1980-06-13|1988-05-09|Shionogi & Co|
    JPS6412277B2|1980-09-27|1989-02-28|Taisho Pharma Co Ltd|
    US5043353A|1989-10-10|1991-08-27|Eli Lilly And Company|A80789 polyether antibiotic|
    US5242814A|1989-10-10|1993-09-07|Eli Lilly And Company|Polyether antibiotic|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US70139576A| true| 1976-06-30|1976-06-30|
    [返回顶部]